Journal article

Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes?

Kamlesh Khunti, Samuel Seidu, Melanie J Davies

Diabetes, Obesity and Metabolism | Published : 2019

University of Melbourne Researchers